πŸ‡ΊπŸ‡Έ FDA
Patent

US 7994209

3-phenoxymethylpyrrolidine compounds

granted A61KA61K31/40A61K45/06

Quick answer

US patent 7994209 (3-phenoxymethylpyrrolidine compounds) held by Theravance, Inc. expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P13/00